Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.60 |
| ▸ | RECQL | P46063 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | NPY1R | P25929 | 1/20 | 0.51 |
| ▸ | NPY2R | P49146 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29742389 | 1.00 | L3MBTL1 (0.68) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL7447113 | 0.92 | L3MBTL1 (0.67) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL7366723 | 0.86 | L3MBTL1 (0.71) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL11128346 | 0.85 | CYP1A2 (0.54) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL11128344 | 0.85 | CYP1A2 (0.54) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| Nitric Acid SCHEMBL8753749 | 0.84 | L3MBTL1 (0.51) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| Nitric Acid SCHEMBL8754463 | 0.84 | L3MBTL1 (0.51) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL27520599 | 0.84 | L3MBTL1 (0.64) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL10453566 | 0.83 | L3MBTL1 (0.62) | L3MBTL1RAB9ANPC1RECQLKMT2A | |
| SCHEMBL2474599 | 0.83 | L3MBTL1 (0.62) | L3MBTL1RAB9ANPC1RECQLKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4061180-A1 | DYEING OR LIGHTENING PROCESS USING A HAND-HELD STYLING DEVICE AND A SUBSTRATE | L'OREAL (FR) | 2022-09-28 | — | — | EP | disclosed |
| CN-113372568-B | Preparation method of neodymium-based or holmium-based chiral metal-organic porous crystalline material, prepared material and application thereof | 合肥工业大学 | 2022-07-22 | — | — | CN | disclosed |
| CN-113372568-A | Preparation method of neodymium-based or holmium-based chiral metal-organic porous crystalline material, prepared material and application thereof | 合肥工业大学 | 2021-09-10 | — | — | CN | disclosed |
| US-10696583-B2 | Composition for strengthening glass | C-BOND SYSTEMS, LLC (US) | 2020-06-30 | — | — | US | disclosed |
| WO-2015097310-A1 | LIGHTENING DYEING PROCESS USING A SUBSTRATE BEARING AT LEAST ONE OXIDIZING AGENT AND AN AQUEOUS COMPOSITION COMPRISING ONE OR MORE DIRECT DYES | L'OREAL (FR) | 2015-07-02 | — | — | WO | disclosed |
| WO-2015097308-A1 | DYEING PROCESS USING AN INSOLUBLE SUBSTRATE BEARING AT LEAST ONE DIRECT DYE AND AN AQUEOUS COMPOSITION | L'OREAL (FR) | 2015-07-02 | — | — | WO | disclosed |
| US-20140141260-A1 | COMPOSITION FOR STRENGTHENING GLASS | ROK INVESTMENT GROUP LIMITED (UK) | 2014-05-22 | — | — | US | disclosed |
| US-8541573-B2 | Substituted sulfonamide compounds | GRUENENTHAL GMBH (DE) | 2013-09-24 | — | — | US | disclosed |
| US-8541573-B2 | Substituted sulfonamide compounds | GRUENENTHAL GMBH (DE) | 2013-09-24 | — | — | US | disclosed |
| WO-2013009691-A1 | COMPOSITION FOR STRENGTHENING GLASS | ROK PROTECTIVE SYSTEMS, INC. (US) | 2013-01-17 | — | — | WO | disclosed |
| US-20090253669-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-10-08 | — | — | US | disclosed |
| WO-2009115257-A1 | SUBSTITUTED SULFONAMIDE DERIVATIVES | Grünenthal GmbH (DE) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009109364-A1 | SUBSTITUTED SULFONAMIDE DERIVATIVES | Grünenthal GmbH (DE) | 2009-09-11 | — | — | WO | disclosed |
| EP-1456362-A2 | METHOD FOR THE GENERATION OF PROTEINS WITH NEW ENZYMATIC FUNCTION | California Institute of Technology (US) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003068907-A2 | METHOD FOR THE GENERATION OF PROTEINS WITH NEW ENZYMATIC FUNCTION | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2003-08-21 | — | — | WO | disclosed |
| US-4209447-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1980-06-24 | — | — | US | disclosed |
| US-4154738-A | 1-(2-AR-4-ARYLOXYMETHYL-1,3-DIOXOLAN-2-YL-METHYL)-IMIDAZOLES, FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-05-15 | — | — | US | disclosed |
| US-4141908-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-02-27 | — | — | US | disclosed |
| US-4139540-A | FUNGICIDE, BACTERICIDE INTERMEDIATE | JANSSEN PHARMACEUTICA N.V. (BE) | 1979-02-13 | — | — | US | disclosed |
| US-4101665-A | FUNGICIDES, BACTERICIDES | JANSSEN PHARMACEUTICA N.V. (BE) | 1978-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253669-A1 | Substituted Sulfonamide Compounds | SULT2A1, STS, SULT1A1 | L3MBTL1 4883/4885RAB9A 2485/4885NPC1 2399/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.